What is Vinpocetine Market?
Vinpocetine has been extensively sold in the country as a dietary supplement for about two decades and booming the market demands for vinpocetine. Vinpocetine is a compound derived from the periwinkle plant – has been observer increasing demand for use as a supplement to improve biological aspects of memory and prevent cognitive impairment. The use of it offers benefits for improving memory and thinking skills, increasing energy, and weight loss, and many more conditions. According to research Stroke is the third leading cause of death in the United States. Of the more than 700,000 people affected every year, about 500,000 of these are first attacks and 200,000 are recurrent. About 25 percent of people who recover from their first stroke will have another stroke within five years.
The market study is being classified by Type (Tablet, Capsules, powders and Others), by Application (Household and Hospital) and major geographies with country level break-up.
Gedeon Richter (Hungary), Pharma Trade (UAE), Pharma Micro Labs (India), Life Extension(United States), Life Extension (United States), Sun Pharma (India), Covex (Spain), Puritan’s Pride (United States), Swanson Superior Herbs (United States) and Pure Encapsulations (United States) are some of the key players profiled in the study.
Global Vinpocetine production is highly fragmented and the market key players major manufacturers have used various strategies such as product launches, acquisitions, agreements, expansions, partnerships, joint ventures, and others to boost their domination over this market. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Vinpocetine market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Vinpocetine market by Type, Application and Region.
On the basis of geography, the market of Vinpocetine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increasing adoption of Dietary supplements
- Growing awareness of calorie reduction and weight loss
- Global healthcare and malnutrition problems are increasing, creating a demand for dietary supplements
Market Trend
- Emerging demand for Vinpocetine as a Dietary supplement
- Emerging demand for vinpocetine for treating stroke, senile dementia and memory disturbances
Restraints
- FDA issues warning for vinpocetine
Opportunities
- Growing claims from companies marketing dietary supplements containing vinpocetine as an active ingredient that the item for consumption to help and improve athletic performance, boost memory loss, and in weight management has lead to the speedy development of the global vinpocetine market.
Challenges
- Adverse effects of Vinpocetine Supplements on Woman
- Lack of knowledge about the consumption of dosage of the supplements
"On September 6, 2016, the FDA announced its tentative conclusion that vinpocetine (1) does not meet the definition of a dietary ingredient, and (2) is excluded from the definition of a dietary supplement in the Federal Food, Drug, and Cosmetic Act (FD&C Act)."
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Vinpocetine Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry